Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 5
2009 12
2010 7
2011 12
2012 9
2013 8
2014 8
2015 12
2016 16
2017 18
2018 14
2019 9
2020 4
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Results by year
Filters applied: . Clear all
Page 1
Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model.
Lodise TP, Smith NM, O'Donnell N, Eakin AE, Holden PN, Boissonneault KR, Zhou J, Tao X, Bulitta JB, Fowler VG, Chambers HF, Bonomo RA, Tsuji BT. Lodise TP, et al. Among authors: bulitta jb. J Antimicrob Chemother. 2020 Sep 1;75(9):2622-2632. doi: 10.1093/jac/dkaa197. J Antimicrob Chemother. 2020. PMID: 32464664
Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials.
Jiao Y, Moya B, Chen MJ, Zavascki AP, Tsai H, Tao X, Sutaria DS, Louie A, Boyce JD, Deveson Lucas D, Kim TH, Tsuji BT, Bonomo RA, Drusano GL, Bulitta JB. Jiao Y, et al. Among authors: bulitta jb. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00425-19. doi: 10.1128/AAC.00425-19. Print 2019 Jul. Antimicrob Agents Chemother. 2019. PMID: 30988147 Free PMC article.
Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis.
Bulitta JB, Jiao Y, Drescher SK, Oliver A, Louie A, Moya B, Tao X, Wittau M, Tsuji BT, Zavascki AP, Shin BS, Drusano GL, Sörgel F, Landersdorfer CB. Bulitta JB, et al. Clin Pharmacokinet. 2019 Feb;58(2):143-156. doi: 10.1007/s40262-018-0678-x. Clin Pharmacokinet. 2019. PMID: 29936678 Review.
Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five β-Lactams Simultaneously in Carbapenem-Resistant Klebsiella pneumoniae and Enterobacter cloacae.
Kim TH, Tao X, Moya B, Jiao Y, Basso KB, Zhou J, Lang Y, Sutaria DS, Zavascki AP, Barth AL, Reeve SM, Schweizer HP, Deveson Lucas D, Boyce JD, Bonomo RA, Lee RE, Shin BS, Louie A, Drusano GL, Bulitta JB. Kim TH, et al. Among authors: bulitta jb. mBio. 2020 Feb 11;11(1):e03189-19. doi: 10.1128/mBio.03189-19. mBio. 2020. PMID: 32047131 Free PMC article.
FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development.
Byrne JM, Waack U, Weinstein EA, Joshi A, Shurland SM, Iarikov D, Bulitta JB, Diep BA, Guina T, Hope WW, Lawrenz MB, Lepak AJ, Luna BM, Miesel L, Phipps AJ, Walsh TJ, Weiss W, Amini T, Farley JJ. Byrne JM, et al. Among authors: bulitta jb. Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01983-20. doi: 10.1128/AAC.01983-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33106262 Review.
Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
Rees VE, Deveson Lucas DS, López-Causapé C, Huang Y, Kotsimbos T, Bulitta JB, Rees MC, Barugahare A, Peleg AY, Nation RL, Oliver A, Boyce JD, Landersdorfer CB. Rees VE, et al. Among authors: bulitta jb. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02538-18. doi: 10.1128/AAC.02538-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30745381 Free PMC article.
125 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page